The immunohistochemistry results show that MR-1 is abundantly expressed in tumor tissues from ovarian cancer patients, particularly those with serous papillary ovarian cancer (Figure 3B), and that MR-1 is expressed in the cytoplasm of ovarian cancer cells (though it is normally localized to the nuclear membrane). Here, MR1 is linked to neoplasm.